ERA-NET subsidy for translational research on human ovarian tumour
Peter Horvatovich, Analytical Biochemistry (Groningen Research institute of Pharmacy), received as consortium partner in TRANSCAN-2, ERA-NET research program 300.000 euro subsidy for translational research on human ovarian tumour heterogeneity to overcome recurrence and resistance to therapy. The project in collaboration with European partners and the labs of Kathrin Thedieck (UMCG), Marco Grzegorczyk (JBI) and Victor Guryev (UMCG) will allow to understand molecular heterogeneity of human primary and metastatic ovarian cancer and open new doors for better patient characterization and personalized treatment of this malignant cancer type, where patients have currently less than 45% of 5-years survival rate.
| Last modified: | 07 April 2016 11.41 a.m. |
More news
-
21 September 2022
Board of the University proud of national coverage of Feringa’s ‘Everyday Molecules’
Last week, Ben Feringa and Anouk Lubbe presented the first copy of their book Alledaagse Moleculen (Everyday Molecules) to minister Robbert Dijkgraaf. The richly illustrated book offers an accessible overview of 180 substances in our daily lives....
-
04 July 2022
Research on how tourists become Antarctic ambassadors
Dr Annette Scheepstra of the UG Arctic Centre, part of the Faculty of Arts, is about to conduct research into tourism in Antarctica and how tourists can become Antarctic ambassadors. She has been granted €1 million in funding by the Dutch Research...
-
12 May 2022
KNAW appoints two UG professors as members
The Royal Netherlands Academy of Arts and Sciences (KNAW) has appointed Professor Maria Loi and Professor Dirk Slotboom from the Faculty of Science and Engineering as members of the Academy.